Full text is available at the source.
The New England journal of medicine···
Using Dexmedetomidine for Early Sedation in Critically Ill Patients
Updated
Abstract
Among 3904 critically ill patients, 29.1% in both the dexmedetomidine and usual-care groups died by 90 days.
- There was no difference in the death rate at 90 days between patients receiving dexmedetomidine and those receiving usual sedative care.
- Patients in the dexmedetomidine group frequently required additional sedatives to maintain the desired sedation level.
- Bradycardia and hypotension were reported more often in the dexmedetomidine group compared to the usual-care group.
Simplified
BACKGROUND: Dexmedetomidine produces sedation while maintaining a degree of arousability and may reduce the duration of mechanical ventilation and delirium among patients in the intensive care unit (ICU). The use of dexmedetomidine as the sole or primary sedative agent in patients undergoing mechanical ventilation has not been extensively studied.
METHODS: In an open-label, randomized trial, we enrolled critically ill adults who had been undergoing ventilation for less than 12 hours in the ICU and were expected to continue to receive ventilatory support for longer than the next calendar day to receive dexmedetomidine as the sole or primary sedative or to receive usual care (propofol, midazolam, or other sedatives). The target range of sedation-scores on the Richmond Agitation and Sedation Scale (which is scored from -5 [unresponsive] to +4 [combative]) was -2 to +1 (lightly sedated to restless). The primary outcome was the rate of death from any cause at 90 days.
RESULTS: We enrolled 4000 patients at a median interval of 4.6 hours between eligibility and randomization. In a modified intention-to-treat analysis involving 3904 patients, the primary outcome event occurred in 566 of 1948 (29.1%) in the dexmedetomidine group and in 569 of 1956 (29.1%) in the usual-care group (adjusted risk difference, 0.0 percentage points; 95% confidence interval, -2.9 to 2.8). An ancillary finding was that to achieve the prescribed level of sedation, patients in the dexmedetomidine group received supplemental propofol (64% of patients), midazolam (3%), or both (7%) during the first 2 days after randomization; in the usual-care group, these drugs were administered as primary sedatives in 60%, 12%, and 20% of the patients, respectively. Bradycardia and hypotension were more common in the dexmedetomidine group.
CONCLUSIONS: Among patients undergoing mechanical ventilation in the ICU, those who received early dexmedetomidine for sedation had a rate of death at 90 days similar to that in the usual-care group and required supplemental sedatives to achieve the prescribed level of sedation. More adverse events were reported in the dexmedetomidine group than in the usual-care group. (Funded by the National Health and Medical Research Council of Australia and others; SPICE III ClinicalTrials.gov number, NCT01728558.).
Related papers
Mar '12
Comparing dexmedetomidine, midazolam, and propofol for sedation during long-term mechanical ventilation in two trials
top 1% journal
cited by 797 papers
randomized controlled trial
Feb '09
Comparing Dexmedetomidine and Midazolam for Sedating Critically Ill Patients in a Randomized Trial
top 1% journal
cited by 1,381 papers
randomized controlled trial
Feb '20
Using No or Light Sedation for Critically Ill Patients on Mechanical Ventilation
🏆 top 0.1% journal
cited by 177 papers
randomized controlled trial
Jun '13
Is Dexmedetomidine Ready for Routine Use in Intensive Care?
top 5% journal
cited by 21 papers
comment
Apr '15
Using alpha-2 agonists for long-term sedation in critically ill patients on mechanical ventilators
cited by 50 papers
systematic review
Feb '21
Sedation with Dexmedetomidine or Propofol in Adults on Ventilators with Sepsis
🏆 top 0.1% journal
cited by 239 papers
randomized controlled trial
Apr '16
Sedation with Alpha-2 Agonists in Mechanically Ventilated Adults in Intensive Care: A Systematic Review
cited by 59 papers
systematic review
Aug '20
Dexmedetomidine Sedation in Critically Ill Children on Mechanical Ventilation: A Small Randomized Trial
top 20% journal
cited by 32 papers
randomized controlled trial
Jul '13
Early focused sedation compared to usual sedation in critically ill patients on ventilators: a pilot study
top 5% journal
cited by 138 papers
randomized controlled trial
Jan '16
Preventing and Managing Delirium in Ventilated ICU Patients by Mimicking Sleep-Wake Cycle Disruption with Sedatives
cited by 1 paper
randomized controlled trial